NEIBARIX
LIVE

Serial Number

98399962

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Feb 9, 2024

Add to watchlist:

No watchlists yet
View on USPTO

NEIBARIX Trademark

Serial Number: 98399962 • Registration: 7641693

NEIBARIX is a trademark filed by GlaxoSmithKline Biologicals SA on February 9, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

February 9, 2024

Registration Date

January 7, 2025

Published for Opposition

October 22, 2024

Goods & Services

Vaccines for human use

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 5, 2024 ERRR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 22, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 12, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 4, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 4, 2024 GNSL
SUSPENSION LETTER WRITTEN
Sep 4, 2024 CNSL
EXAMINER'S AMENDMENT ENTERED
Sep 4, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 4, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 4, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 4, 2024 CNEA
ASSIGNED TO EXAMINER
Aug 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2024 NWOS
NEW APPLICATION ENTERED
Feb 9, 2024 NWAP